Aadi Bioscience Inc (AADI)
1.85
-0.05
(-2.63%)
USD |
NASDAQ |
Apr 23, 16:00
1.85
0.00 (0.00%)
After-Hours: 19:39
Aadi Bioscience Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | -0.8149 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.8149
Minimum
Dec 2020
--
Maximum
Sep 2021
-0.0741
Average
--
Median
Sep 2021
Debt to Equity Ratio Benchmarks
| Aquestive Therapeutics Inc | -0.2585 |
| 89bio Inc | -- |
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 132.42M |
| Total Liabilities (Quarterly) | 27.23M |
| Shareholders Equity (Quarterly) | 105.20M |
| Current Ratio | 4.720 |